Study of QLS5212 for people with advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called QLS5212 in people with solid tumors that have spread or cannot be removed by surgery. The goal is to see if the drug is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- Your cancer must be advanced (spread or not removable by surgery) and confirmed by biopsy.
- You must be well enough to care for yourself (ECOG score 0 or 1).
- You must have at least one tumor that can be measured on a CT or MRI scan.
- You must have acceptable blood counts and liver/kidney function.
- You must have a stored tumor sample from a previous biopsy or be willing to provide one.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called QLS5133 for people with advanced solid tumors (cancers that have spread). The drug may help shrink tumors or slow their growth. The study is in two phases to find the right dose and see how well it works.
This study tests an experimental drug called QLS5132 for people with advanced solid tumors (cancers that start in organs or tissues). The drug targets a protein called CLDN6 on some cancer cells and might help stop the tumor from growing.
This trial tests an experimental drug called QLS5316 in people with advanced solid tumors that have stopped responding to standard treatment or for which no standard treatment exists. The goal is to find the right dose and see how well it shrinks or controls the cancer.
This trial tests an experimental drug, QLS-1304, for people with advanced solid tumors that have stopped responding to standard treatment. The goal is to see if the drug is safe and effective.
This trial tests an experimental drug (called QLS5308) for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug can shrink tumors or slow their growth, and to find the best dose with manageable side effects.
This Phase 1 trial tests the safety and how the medicine works in the body, and also looks at early signs of effectiveness. It is for adults with advanced solid tumors, and for Phase 1b specifically, the tumor must show a marker called GPC3.
Hear when a new Solid Tumor Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.